709 related articles for article (PubMed ID: 13679459)
41. Hypermethylation of the p16 gene promoter in pterygia and its association with the expression of DNA methyltransferase 3b.
Chen PL; Cheng YW; Chiang CC; Tseng SH; Chau PS; Tsai YY
Mol Vis; 2006 Nov; 12():1411-6. PubMed ID: 17149367
[TBL] [Abstract][Full Text] [Related]
42. Deleted in colorectal cancer is a putative conditional tumor-suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinoma.
Carvalho AL; Chuang A; Jiang WW; Lee J; Begum S; Poeta L; Zhao M; Jerónimo C; Henrique R; Nayak CS; Park HL; Brait MR; Liu C; Zhou S; Koch W; Fazio VM; Ratovitski E; Trink B; Westra W; Sidransky D; Moon CS; Califano JA
Cancer Res; 2006 Oct; 66(19):9401-7. PubMed ID: 17018594
[TBL] [Abstract][Full Text] [Related]
43. p16(INK4a) promoter methylation and 9p21 allelic loss in colorectal carcinomas: relation with immunohistochemical p16(INK4a) expression and with tumor budding.
Prall F; Ostwald C; Weirich V; Nizze H
Hum Pathol; 2006 May; 37(5):578-85. PubMed ID: 16647956
[TBL] [Abstract][Full Text] [Related]
44. Inactivation of the cyclin-dependent kinase inhibitor 2A (CDKN2A) gene in squamous cell carcinoma of the larynx.
Smigiel R; Sasiadek M; Krecicki T; Ramsey D; Jagielski J; Blin N
Mol Carcinog; 2004 Mar; 39(3):147-54. PubMed ID: 14991744
[TBL] [Abstract][Full Text] [Related]
45. Epigenetic abnormalities in cutaneous squamous cell carcinomas: frequent inactivation of the RB1/p16 and p53 pathways.
Murao K; Kubo Y; Ohtani N; Hara E; Arase S
Br J Dermatol; 2006 Nov; 155(5):999-1005. PubMed ID: 17034532
[TBL] [Abstract][Full Text] [Related]
46. Significance of promoter hypermethylation of p16 gene for margin assessment in carcinoma tongue.
Sinha P; Bahadur S; Thakar A; Matta A; Macha M; Ralhan R; Gupta SD
Head Neck; 2009 Nov; 31(11):1423-30. PubMed ID: 19431196
[TBL] [Abstract][Full Text] [Related]
47. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
Rodrigo JP; García-Carracedo D; García LA; Menéndez S; Allonca E; González MV; Fresno MF; Suárez C; García-Pedrero JM
J Pathol; 2009 Mar; 217(4):516-23. PubMed ID: 18991334
[TBL] [Abstract][Full Text] [Related]
48. Differential methylation status of tumor-associated genes in head and neck squamous carcinoma: incidence and potential implications.
Maruya S; Issa JP; Weber RS; Rosenthal DI; Haviland JC; Lotan R; El-Naggar AK
Clin Cancer Res; 2004 Jun; 10(11):3825-30. PubMed ID: 15173091
[TBL] [Abstract][Full Text] [Related]
49. Promoter hypermethylation of the p16 gene is associated with poor prognosis in recurrent early-stage hepatocellular carcinoma.
Ko E; Kim Y; Kim SJ; Joh JW; Song S; Park CK; Park J; Kim DH
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2260-7. PubMed ID: 18723830
[TBL] [Abstract][Full Text] [Related]
50. Comparison of p16(INK4a) expression with p53 alterations in head and neck cancer by tissue microarray analysis.
Karsai S; Abel U; Roesch-Ely M; Affolter A; Hofele C; Joos S; Plinkert PK; Bosch FX
J Pathol; 2007 Feb; 211(3):314-22. PubMed ID: 17152048
[TBL] [Abstract][Full Text] [Related]
51. The correlation between CpG methylation and protein expression of P16 in oral squamous cell carcinomas.
Huang MJ; Yeh KT; Shih HC; Wang YF; Lin TH; Chang JY; Shih MC; Chang JG
Int J Mol Med; 2002 Nov; 10(5):551-4. PubMed ID: 12373290
[TBL] [Abstract][Full Text] [Related]
52. Differential expression of key cell cycle genes (p16/cyclin D1/pRb) in head and neck squamous carcinomas.
Lai S; El-Naggar AK
Lab Invest; 1999 Mar; 79(3):255-60. PubMed ID: 10092061
[TBL] [Abstract][Full Text] [Related]
53. The ARF-p16 gene locus in carcinogenesis and therapy of head and neck squamous cell carcinoma.
Yarbrough WG
Laryngoscope; 2002 Dec; 112(12):2114-28. PubMed ID: 12461329
[TBL] [Abstract][Full Text] [Related]
54. Familial head and neck cancer: molecular analysis of a new clinical entity.
Yu KK; Zanation AM; Moss JR; Yarbrough WG
Laryngoscope; 2002 Sep; 112(9):1587-93. PubMed ID: 12352668
[TBL] [Abstract][Full Text] [Related]
55. Aberrant methylation of p14(ARF), p15(INK4b) and p16(INK4a) genes and location of the primary site in pulmonary squamous cell carcinoma.
Furonaka O; Takeshima Y; Awaya H; Ishida H; Kohno N; Inai K
Pathol Int; 2004 Aug; 54(8):549-55. PubMed ID: 15260845
[TBL] [Abstract][Full Text] [Related]
56. Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma.
Okami K; Reed AL; Cairns P; Koch WM; Westra WH; Wehage S; Jen J; Sidransky D
Oncogene; 1999 Jun; 18(23):3541-5. PubMed ID: 10376532
[TBL] [Abstract][Full Text] [Related]
57. Overexpression of E2F-1 is associated with increased disease-free survival in squamous cell carcinoma of the anterior tongue.
Kwong RA; Nguyen TV; Bova RJ; Kench JG; Cole IE; Musgrove EA; Henshall SM; Sutherland RL
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3705-11. PubMed ID: 14506162
[TBL] [Abstract][Full Text] [Related]
58. Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma.
Chung CH; Parker JS; Ely K; Carter J; Yi Y; Murphy BA; Ang KK; El-Naggar AK; Zanation AM; Cmelak AJ; Levy S; Slebos RJ; Yarbrough WG
Cancer Res; 2006 Aug; 66(16):8210-8. PubMed ID: 16912200
[TBL] [Abstract][Full Text] [Related]
59. Differential roles of p16INK4A and p14ARF genes in prognosis of oral carcinoma.
Sailasree R; Abhilash A; Sathyan KM; Nalinakumari KR; Thomas S; Kannan S
Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):414-20. PubMed ID: 18268126
[TBL] [Abstract][Full Text] [Related]
60. In situ analysis of p16/INK4 promoter hypermethylation in esophageal carcinoma and gastric carcinoma.
Zhang F; Wang L; Wu PP; Yan ZW; Zheng L; Yu YY; Jiang XC
Chin J Dig Dis; 2004; 5(4):149-55. PubMed ID: 15612883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]